Links to publications that use this kit:

Tasci et al. LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia.
Atherosclerosis. 2009 May;204(1):222-8.

Dray et al. Apelin Stimulates Glucose Utilization in Normal and Obese Insulin-Resistant Mice
Cell Metab. 2008 Nov;8(5):437-45.

Mazzucotelli et al. The transcriptional co-activator PGC-1alpha up regulates apelin in human and mouse adipocytes.
Regul Pept. 2008 Oct 9;150(1-3):33-7.

Japp et al. Vascular effects of apelin in vivo in man.
J Am Coll Cardiol. 2008 Sep 9;52(11):908-13.

Malamitsi-Puchner et al. Circulating apelin concentrations in mother/infant pairs at term
Acta Paediatr. 2007 Dec;96(12):1751-4.

Glassford et al. HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes
Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1590-6.

Hashimoto et al. Requirement of Apelin-Apelin Receptor System for Oxidative Stress-Linked Atherosclerosis
Am J Pathol. 2007 Nov;171(5):1705-12. 

Francia et al. Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin
Eur J Heart Fail. 2007 Mar;9(3):306-9.

Boso et al. Reduced Plasma Apelin Levels in Patients with Autistic Spectrum Disorder
Arch Med Res. 2007 Jan;38(1):70-4. 

Codognotto et al. Evidence for Decreased Circulating Apelin beyond Heart Involvement in Uremic Cardiomyopathy
Am J Nephrol. 2007;27(1):1-6.

Iwanaga et al. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-angiotensin type 1 receptor system.
J Mol Cell Cardiol. 2006 Nov;41(5):798-806.

Ellinor et al. Reduced apelin levels in lone atrial fibrillation.
Eur Heart J. 2006 Jan;27(2):222-6.

Boucher et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity.
Endocrinology. 2005 Apr;146(4):1764-71.

Chen et al. Novel Role for the Potent Endogenous Inotrope Apelin in Human Cardiac Dysfunction
Circulation. 2003 Sep 23;108(12):1432-9.